Please provide your email address to receive an email when new articles are posted on . The study included 58 young persons with migraine flares lasting 24 hours to 3 months. A majority of those given ...
Elsewhere in the migraine prevention field, Lundbeck markets the infused drug Vyepti in the crowded CGRP inhibitor space. The ...
According to current data, migraines are one of the most common neurological disorders worldwide and in the United States. Worldwide, migraines affect about 40% of the population (3.1 billion people).
Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5%. HealthDay News — Diagnostic targeted Botox injections have high positive predictive value for migraine ...
The middle meningeal artery (MMA) has emerged as a potential therapeutic target for severe, treatment-resistant headache ...
Teva Canada Limited (Teva Canada) announced today that Health Canada has approved an expanded indication for PrAJOVY® ...
Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
Shares of Amneal Pharmaceuticals, Inc. (AMRX) traded marginally higher on Thursday morning after the U.S. Food and Drug Administration (FDA) approved its self-administrable Brekiya injection for ...
It began as an odd observation among plastic surgery patients, and ended up as an FDA approved drug — on Friday, the agency green-lighted the use of Botox, a popular wrinkle-reducing procedure, to ...
“When I got here in Muscatine, we were looking at needs in the community and discovered that there is a real lack of access to neurology and migraine management in the area, so given that I had some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results